Oxytocin ISMP Best Practice - Part E

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jgold@ismp.org. 

1 post / 0 new
Log in or register to post comments
Wed, 06/01/2022 - 11:52
#1
Joel W Daniel
Joel W Daniel's picture
Offline
Last seen: 1 week 1 day ago
Joined: 01/25/2018 - 09:33
Oxytocin ISMP Best Practice - Part E

For those that have already done this, or are in the middle of mitigating this:

We appear to have some buy-in with oxytocin regarding the ISMP best practice, but we have not seen movement on the last portion of the recommendation in the actual data. It reads, "avoid bringing oxytocin infusion bags to the patient's bedside until it is prescribed and needed."

What have you found that can help change hearts and minds in this arena? Are there posters or something that someone can point to that would help?

Top